Suppr超能文献

从v-mpl癌基因到血小板生成素。

From the v-mpl oncogene to thrombopoietin.

作者信息

Methia N, Debili N, Titeux M, Vainchenker W, Wendling F

机构信息

INSERM U. 362, Institut Gustave-Roussy, Villejuif, France.

出版信息

C R Acad Sci III. 1995 Apr;318(4):479-82.

PMID:7648360
Abstract

v-mpl is a mouse oncogene that is part of the genome of the myeloproliferative leukemia virus (MPLV). The cellular homolog gene c-mpl encodes an hematopoietic cytokine receptor restricted to the megakaryocytic lineage of differentiation. Using the Mpl receptor protein, cDNAs corresponding to the receptor ligand were isolated in humans, pigs, dogs and mice. In vivo and in vitro, the recombinant molecule has both the thrombopoietin (TPO) and megakaryocyte-colony stimulating factor (MK-CSF) activities. This molecule (Mpl ligand/TPO/MK-CSF) is the humoral physiological regulator of platelet production.

摘要

v-mpl是一种小鼠癌基因,是骨髓增殖性白血病病毒(MPLV)基因组的一部分。细胞同源基因c-mpl编码一种造血细胞因子受体,该受体仅限于巨核细胞分化谱系。利用Mpl受体蛋白,在人、猪、狗和小鼠中分离出了与受体配体对应的cDNA。在体内和体外,重组分子同时具有血小板生成素(TPO)和巨核细胞集落刺激因子(MK-CSF)活性。这种分子(Mpl配体/TPO/MK-CSF)是血小板生成的体液生理调节因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验